Sort
17,288 grants matching “multiple sclerosis”
Regulation of TH17 Cell Development and Function by the REV-ERBs
$480,000Laura A Solt · Scripps Florida · R01 · FY2017 · AI
Regulation of TH17 cell development and function by the REV-ERBs
$480,000Laura A Solt · Scripps Florida · R56 · FY2015 · AI
Development and Validation of Measures of Pain Behaviors in Chronic Pain
$479,966Dagmar Amtmann · University Of Washington · RC1 · FY2010 · NR
Viruses and Autoimmunity
$479,822La Jolla Inst For Allergy &Immunolgy · P01 · FY2005 · AI
A Novel Tolerance Therapeutic for Treating Multiple Sclerosis
$479,708Neil A Fanger · Virtici, Llc · R44 · FY2016 · AI
In Vivo Imaging of Cortical Glial Activation Using Advanced Diffusion Magnetic Resonance Imaging
$479,639Caterina Mainero · Massachusetts General Hospital · R21 · FY2021 · NS
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
$479,619William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2015 · CA
Regulation of R-loop Formation and Genome Stability by ADAR1
$479,470Kazuko Nishikura · Wistar Institute · R01 · FY2020 · GM
Regulation of R-loop Formation and Genome Stability by ADAR1
$479,470Kazuko Nishikura · Wistar Institute · R01 · FY2019 · GM
Regulation of R-loop Formation and Genome Stability by ADAR1
$479,470Kazuko Nishikura · Wistar Institute · R01 · FY2021 · GM
Regulation of R-loop Formation and Genome Stability by ADAR1
$479,470Kazuko Nishikura · Wistar Institute · R01 · FY2018 · GM
Gliovascular Mechanisms of Blood-Brain Barrier Disruption in Neuroinflammatory Disease
$479,425Dimitrios Davalos · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · NS
Gliovascular Mechanisms of Blood-Brain Barrier Disruption in Neuroinflammatory Disease
$479,424Dimitrios Davalos · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · NS
Gliovascular Mechanisms of Blood-Brain Barrier Disruption in Neuroinflammatory Disease
$479,424Dimitrios Davalos · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS
Gliovascular Mechanisms of Blood-Brain Barrier Disruption in Neuroinflammatory Disease
$479,424Dimitrios Davalos · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · NS
Modeling and Analysis of Clinical Care for HIT Improvement
$479,244Keith Butler · University Of Washington · R01 · FY2012 · HS
Blood-Brain Barrier Dysfunction and Brain Injury in Heart Failure
$479,084Mary Ann Woo · University Of California Los Angeles · R01 · FY2015 · NR
Overcoming the Inhibitory Neurovascular Niche in Preterm Infant Brain Injury
$479,072Mark A Petersen · University Of California, San Francisco · R01 · FY2023 · NS
Functional Anatomy of Neuroimmune Interactions
$478,795Paul E. Sawchenko · Salk Institute For Biological Studies · R01 · FY2010 · NS
RESTORATIVE NEUROIMMUNOLOGY IN EXPERIMENTAL MODELS OF MULTIPLE SCLEROSIS VIA DIRECTLY INDUCED NEURAL STEM CELL TRANSPLANTATION.
$478,783The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2015 · Department of the Army
Beta-lactam chemical probes for GLT-1 transporter-related pathologies
$478,707Scott M Rawls · Temple Univ Of The Commonwealth · RC1 · FY2009 · DA
PET SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1PR1) RADIOTRACERS FOR MULTIPLE SCLEROSIS
$478,679Zhude Tu · Washington University · R01 · FY2017 · NS
Modulation of Inflammatory Responses by Helminth Glycans
$478,549Richard D Cummings · Emory University · R01 · FY2014 · AI
Novel Use of Zebrafish for Apoptosis Assay
$478,538Phylonix Pharmaceuticals, Inc. · R44 · FY2004 · CA
Regulation of encephalitogenic T cells by CRAC channels
$478,517Stefan Feske · New York University School Of Medicine · R01 · FY2019 · AI